ArticlePharmacogenetics and genomics2012

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

James C Sacco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.